Compare SOTK & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOTK | SRTS |
|---|---|---|
| Founded | 1975 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.8M | 65.5M |
| IPO Year | 1995 | 2016 |
| Metric | SOTK | SRTS |
|---|---|---|
| Price | $4.18 | $4.49 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 19.2K | ★ 36.5K |
| Earning Date | 05-27-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | $20,504,381.00 | ★ $27,482,000.00 |
| Revenue This Year | $4.02 | $2.00 |
| Revenue Next Year | $10.95 | $34.23 |
| P/E Ratio | $52.38 | ★ N/A |
| Revenue Growth | ★ 4.08 | N/A |
| 52 Week Low | $3.23 | $3.03 |
| 52 Week High | $5.15 | $5.92 |
| Indicator | SOTK | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 53.13 | 54.76 |
| Support Level | $4.03 | $3.66 |
| Resistance Level | $4.22 | $4.62 |
| Average True Range (ATR) | 0.15 | 0.27 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 68.42 | 79.22 |
Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.